Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-16-087769
Filing Date
2016-01-04
Accepted
2016-01-04 17:02:56
Documents
1
Period of Report
2016-01-01

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 4553
  Complete submission text file 0001104659-16-087769.txt   6056
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address PARADIESSTRASSE 73 BINNINGEN, BASELLAND V8 CH 4102
Business Address
Knowles Jonathan Kenneth Charles (Reporting) CIK: 0001662103 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37368 | Film No.: 161318917